Abaasa, A., G. Asiki, M. A. Price, E. Ruzagira, F. Kibengo, U. Bahemuka, P. E. Fast and A. Kamali (2016). "Comparison of HIV incidence estimated in clinical trial and observational cohort settings in a high risk fishing population in Uganda: Implications for sample size estimates." Vaccine.

 

 

Abdul-Jawad, S., B. Ondondo, A. van Hateren, A. Gardner, T. Elliott, B. Korber and T. Hanke (2016). "Increased valency of conserved-mosaic vaccines enhances the breadth and depth of epitope recognition." Mol Ther. In Press 2016

  

Adler, S. P., A.-M. Manganello, R. Lee, M. A. McVoy, D. E. Nixon, S. Plotkin, E. Mocarski, J. H. Cox, P. E. Fast, P. A. Nesterenko, S. E. Murray, A. B. Hill and G. Kemble (2016). "A Phase 1 Study of Four Live, Recombinant Human Cytomegalovirus Towne/Toledo Chimera Vaccines in CMV Seronegative Men." Journal of Infectious Diseases.

 

Ahmed, T., N. J. Borthwick, J. Gilmour, P. Hayes, L. Dorrell and T. Hanke (2016). "Control of HIV-1 replication in vitro by vaccine-induced human CD8 T cells through conserved subdominant Pol epitopes." Vaccine.

 

 

Baden, L. R., E. Karita, G. Mutua, L. G. Bekker, G. Gray, L. Page-Shipp, S. R. Walsh, J. Nyombayire, O. Anzala, S. Roux, F. Laher, C. Innes, M. S. Seaman, Y. Z. Cohen, L. Peter, N. Frahm, M. J. McElrath, P. Hayes, E. Swann, N. Grunenberg, M. Grazia-Pau, M. Weijtens, J. Sadoff, L. Dally, A. Lombardo, J. Gilmour, J. Cox, R. Dolin, P. Fast, D. H. Barouch and D. S. Laufer (2016). "Assessment of the Safety and Immunogenicity of 2 Novel Vaccine Platforms for HIV-1 Prevention: A Randomized Trial." Ann Intern Med.

 

 

Bergin, P., R. Langat, G. Omosa-Manyonyi, B. Farah, G. Ouattara, H. Park, H. Coutinho, D. Laufer, P. Fast, C. Verlinde, J. Bizimana, G. Umviligihozo, J. Nyombayire, R. Ingabire, K. Kuldanek, J. Cox, M. McMorrow, S. Fidler, E. Karita, J. Gilmour and O. Anzala (2016). "Assessment of anti-HIV-1 antibodies in Oral and Nasal Compartments of Volunteers from Three different Populations." J Acquir Immune Defic Syndr.

 

Bonsignori, M., T. Zhou, Z. Sheng, L. Chen, F. Gao, M. G. Joyce, G. Ozorowski, G. Y. Chuang, C. A. Schramm, K. Wiehe, S. M. Alam, T. Bradley, M. A. Gladden, K. K. Hwang, S. Iyengar, A. Kumar, X. Lu, K. Luo, M. C. Mangiapani, R. J. Parks, H. Song, P. Acharya, R. T. Bailer, A. Cao, A. Druz, I. S. Georgiev, Y. D. Kwon, M. K. Louder, B. Zhang, A. Zheng, B. J. Hill, R. Kong, C. Soto, N. C. S. Program, J. C. Mullikin, D. C. Douek, D. C. Montefiori, M. A. Moody, G. M. Shaw, B. H. Hahn, G. Kelsoe, P. T. Hraber, B. T. Korber, S. D. Boyd, A. Z. Fire, T. B. Kepler, L. Shapiro, A. B. Ward, J. R. Mascola, H. X. Liao, P. D. Kwong and B. F. Haynes (2016). "Maturation Pathway from Germline to Broad HIV-1 Neutralizer of a CD4-Mimic Antibody." Cell.

 

Briney, B., D. Sok, J. G. Jardine, D. W. Kulp, P. Skog, S. Menis, R. Jacak, O. Kalyuzhniy, N. de Val, F. Sesterhenn, K. M. Le, A. Ramos, M. Jones, K. L. Saye-Francisco, T. R. Blane, S. Spencer, E. Georgeson, X. Hu, G. Ozorowski, Y. Adachi, M. Kubitz, A. Sarkar, I. A. Wilson, A. B. Ward, D. Nemazee, D. R. Burton and W. R. Schief (2016). "Tailored Immunogens Direct Affinity Maturation toward HIV Neutralizing Antibodies." Cell 166(6): 1459-1470 e1411.

 

Byrne, E. H., M. N. Anahtar, K. E. Cohen, A. Moodley, N. Padavattan, N. Ismail, B. A. Bowman, G. S. Olson, A. Mabhula, A. Leslie, T. Ndung'u, B. D. Walker, M. S. Ghebremichael, K. L. Dong and D. S. Kwon (2016). "Association between injectable progestin-only contraceptives and HIV acquisition and HIV target cell frequency in the female genital tract in South African women: a prospective cohort study." Lancet Infect Dis.

 

 

Carlson, J. M., V. Y. Du, N. Pfeifer, A. Bansal, V. Y. F. Tan, K. Power, C. J. Brumme, A. Kreimer, C. E. DeZiel, N. Fusi, M. Schaefer, M. A. Brockman, J. Gilmour, M. A. Price, W. Kilembe, R. Haubrich, M. John, S. Mallal, R. Shapiro, J. Frater, P. R. Harrigan, T. Ndung'u, S. Allen, D. Heckerman, J. Sidney, T. M. Allen, P. J. R. Goulder, Z. L. Brumme, E. Hunter and P. A. Goepfert (2016). "Impact of pre-adapted HIV transmission." Nat Med advance online publication.

               

 

Chen, Y., R. Wilson, S. O'Dell, J. Guenaga, Y. Feng, K. Tran, C. I. Chiang, H. E. Arendt, J. DeStefano, J. R. Mascola, R. T. Wyatt and Y. Li (2016). "An HIV-1 Env-Antibody Complex Focuses Antibody Responses to Conserved Neutralizing Epitopes." J Immunol 197(10): 3982-3998.

 

 

 

Curno, M. J., S. Rossi, I. Hodges-Mameletzis, R. Johnston, M. A. Price and S. Heidari (2016). "A systematic review of the inclusion (or exclusion) of women in HIV research: from clinical studies of antiretrovirals and vaccines to cure strategies." J Acquir Immune Defic Syndr. In press 2016

 

 

Dai, K., S. N. Khan, Y. Wang, L. He, J. Guenaga, J. Ingale, C. Sundling, S. O'Dell, K. McKee, G. Phad, M. Corcoran, R. Wilson, J. R. Mascola, J. Zhu, Y. Li, G. B. Karlsson Hedestam and R. T. Wyatt (2016). "HIV-1 Vaccine-elicited Antibodies Reverted to Their Inferred Naive Germline Reveal Associations between Binding Affinity and in vivo Activation." Sci Rep 6: 20987.

 

Das, S., S. Boliar, N. Mitra, S. Samal, M. Bansal, W. C. Koff and B. K. Chakrabarti (2016). "Membrane bound modified form of clade B Env, JRCSF is suitable for immunogen design as it is efficiently cleaved and displays all the broadly neutralizing epitopes including V2 and C2 domain-dependent conformational epitopes." Retrovirology 13(1): 81.

 

 

Deshpande, S., S. Patil, R. Kumar, T. Shrivastava, A. Srikrishnan, K. Murugavel, W. Koff, B. Chakrabarti and J. Bhattacharya (2016). "Association of mutations in V3/C3 domain with enhanced sensitivity of HIV-1 clade C primary envelopes to autologous broadly neutralizing plasma antibodies." Retrovirology 13(1): 41.

 

 

Deshpande, S., S. Patil, R. Kumar, T. Hermanus, K. G. Murugavel, A. K. Srikrishnan, S. Solomon, L. Morris and J. Bhattacharya (2016). "HIV-1 clade C escapes broadly neutralizing autologous antibodies with N332 glycan specificity by distinct mechanisms." Retrovirology 13(1): 60.

 

Escolano, A., J. M. Steichen, P. Dosenovic, D. W. Kulp, J. Golijanin, D. Sok, N. T. Freund, A. D. Gitlin, T. Oliveira, T. Araki, S. Lowe, S. T. Chen, J. Heinemann, K. H. Yao, E. Georgeson, K. L. Saye-Francisco, A. Gazumyan, Y. Adachi, M. Kubitz, D. R. Burton, W. R. Schief and M. C. Nussenzweig (2016). "Sequential Immunization Elicits Broadly Neutralizing Anti-HIV-1 Antibodies in Ig Knockin Mice." Cell 166(6): 1445-1458 e1412.

               

Feng, Y., K. Tran, S. Bale, S. Kumar, J. Guenaga, R. Wilson, N. de Val, H. Arendt, J. DeStefano, A. B. Ward and R. T. Wyatt (2016). "Thermostability of Well-Ordered HIV Spikes Correlates with the Elicitation of Autologous Tier 2 Neutralizing Antibodies." PLoS Pathog 12(8): e1005767.

 

Guenaga, J., V. Dubrovskaya, N. de Val, S. K. Sharma, B. Carrette, A. B. Ward and R. T. Wyatt (2016). "Structure-guided redesign increases the propensity of HIV Env to generate highly stable soluble trimers." J Virol.

 

 

Harmon, T. M., K. A. Fisher, M. G. McGlynn, J. Stover, M. J. Warren, Y. Teng and A. Naveke (2016). "Exploring the Potential Health Impact and Cost-Effectiveness of AIDS Vaccine within a Comprehensive HIV/AIDS Response in Low- and Middle-Income Countries." PLoS One 11(1): e0146387.

 

 

Hayes, P. J., J. H. Cox, A. R. Coleman, N. Fernandez, P. J. Bergin, J. T. Kopycinski, S. Nitayaphan, P. Pitisuttihum, M. de Souza, A. Duerr, C. Morgan and J. W. Gilmour (2016). "Adenovirus based HIV-1 vaccine candidates tested in efficacy trials elicit CD8 T-cells with limited breadth of HIV-1 inhibition." AIDS.

 

He, L., N. de Val, C. D. Morris, N. Vora, T. C. Thinnes, L. Kong, P. Azadnia, D. Sok, B. Zhou, D. R. Burton, I. A. Wilson, D. Nemazee, A. B. Ward and J. Zhu (2016). "Presenting native-like trimeric HIV-1 antigens with self-assembling nanoparticles." Nat Commun 7: 12041.

 

Ingale, J., A. Stano, J. Guenaga, Shailendra K. Sharma, D. Nemazee, Michael B. Zwick and Richard T. Wyatt "High-Density Array of Well-Ordered HIV-1 Spikes on Synthetic Liposomal Nanoparticles Efficiently Activate B Cells." Cell Reports.

 

Irimia, A., A. Sarkar, R. L. Stanfield and I. A. Wilson (2016). "Crystallographic Identification of Lipid as an Integral Component of the Epitope of HIV Broadly Neutralizing Antibody 4E10." Immunity 44(1): 21-31.

 

Kassanjee, R., C. D. Pilcher, M. P. Busch, G. Murphy, S. N. Facente, S. M. Keating, E. McKinney, K. Marson, M. A. Price, J. N. Martin, S. J. Little, F. M. Hecht, E. G. Kallas, A. Welte, E. Consortium For The and A. Performance Of Hiv Incidence (2016). "Viral load criteria and threshold optimization to improve HIV incidence assay characteristics - a CEPHIA analysis." AIDS.

 

Kamali, A., R. N. Nsubuga, E. Ruzagira, U. Bahemuka, G. Asiki, M. A. Price, R. Newton, P. Kaleebu and P. Fast (2016). "Heterogeneity of HIV incidence: a comparative analysis between fishing communities and in a neighbouring rural general population, Uganda, and implications for HIV control." Sex Transm Infect.

 

Kong, L., L. He, N. de Val, N. Vora, C. D. Morris, P. Azadnia, D. Sok, B. Zhou, D. R. Burton, A. B. Ward, I. A. Wilson and J. Zhu (2016). "Uncleaved prefusion-optimized gp140 trimers derived from analysis of HIV-1 envelope metastability." Nat Commun 7: 12040.

 

Kong, L., B. Ju, Y. Chen, L. He, L. Ren, J. Liu, K. Hong, B. Su, Z. Wang, G. Ozorowski, X. Ji, Y. Hua, Y. Chen, Marc C. Deller, Y. Hao, Y. Feng, F. Garces, R. Wilson, K. Dai, S. O’Dell, K. McKee, John R. Mascola, Andrew B. Ward, Richard T. Wyatt, Y. Li, Ian A. Wilson, J. Zhu and Y. Shao "Key gp120 Glycans Pose Roadblocks to the Rapid Development of VRC01-Class Antibodies in an HIV-1-Infected Chinese Donor." Immunity.

 

 

Koff, W. C. (2016). "A shot at AIDS." Curr Opin Biotechnol 42: 147-151.

 

Kong, R., K. Xu, T. Zhou, P. Acharya, T. Lemmin, K. Liu, G. Ozorowski, C. Soto, J. D. Taft, R. T. Bailer, E. M. Cale, L. Chen, C. W. Choi, G.-Y. Chuang, N. A. Doria-Rose, A. Druz, I. S. Georgiev, J. Gorman, J. Huang, M. G. Joyce, M. K. Louder, X. Ma, K. McKee, S. O’Dell, M. Pancera, Y. Yang, S. C. Blanchard, W. Mothes, D. R. Burton, W. C. Koff, M. Connors, A. B. Ward, P. D. Kwong and J. R. Mascola (2016). "Fusion peptide of HIV-1 as a site of vulnerability to neutralizing antibody." Science 352(6287): 828-833.

 

 

Krumm, S. A., H. Mohammed, K. M. Le, M. Crispin, T. Wrin, P. Poignard, D. R. Burton and K. J. Doores (2016). "Mechanisms of escape from the PGT128 family of anti-HIV broadly neutralizing antibodies." Retrovirology 13(1): 8.

 

 

Koff, W. C. and T. Schenkelberg (2016). "Decoding the Human Immune System to Transform the Future of Global Disease Prevention and Control." Expert Rev Vaccines.

 

Karuga, R. N., S. N. Njenga, R. Mulwa, N. Kilonzo, P. Bahati, K. O'Reilley, L. Gelmon, S. Mbaabu, C. Wachihi, G. Githuka and M. Kiragu (2016). ""How I Wish This Thing Was Initiated 100 Years Ago!" Willingness to Take Daily Oral Pre-Exposure Prophylaxis among Men Who Have Sex with Men in Kenya." PLoS One 11(4): e0151716.

 

Longo, N. S., M. S. Sutton, A. R. Shiakolas, J. Guenaga, M. C. Jarosinski, I. S. Georgiev, K. McKee, R. T. Bailer, M. K. Louder, S. O'Dell, M. Connors, R. T. Wyatt, J. R. Mascola and N. A. Doria-Rose (2016). "Multiple antibody lineages in one donor target the glycan-V3 supersite of the HIV-1 envelope glycoprotein and display a preference for quaternary binding." J Virol.

 

 

Jardine, J. G., D. W. Kulp, C. Havenar-Daughton, A. Sarkar, B. Briney, D. Sok, F. Sesterhenn, J. Ereno-Orbea, O. Kalyuzhniy, I. Deresa, X. Hu, S. Spencer, M. Jones, E. Georgeson, Y. Adachi, M. Kubitz, A. C. deCamp, J. P. Julien, I. A. Wilson, D. R. Burton, S. Crotty and W. R. Schief (2016). "HIV-1 broadly neutralizing antibody precursor B cells revealed by germline-targeting immunogen." Science 351(6280): 1458-1463.

 

Jardine, J. G., D. Sok, J. P. Julien, B. Briney, A. Sarkar, C. H. Liang, E. A. Scherer, C. J. Henry Dunand, Y. Adachi, D. Diwanji, J. Hsueh, M. Jones, O. Kalyuzhniy, M. Kubitz, S. Spencer, M. Pauthner, K. L. Saye-Francisco, F. Sesterhenn, P. C. Wilson, D. M. Galloway, R. L. Stanfield, I. A. Wilson, D. R. Burton and W. R. Schief (2016). "Minimally Mutated HIV-1 Broadly Neutralizing Antibodies to Guide Reductionist Vaccine Design." PLoS Pathog 12(8): e1005815.

               

               

Landais, E., X. Huang, C. Havenar-Daughton, B. Murrell, M. A. Price, L. Wickramasinghe, A. Ramos, C. B. Bian, M. Simek, S. Allen, E. Karita, W. Kilembe, S. Lakhi, M. Inambao, A. Kamali, E. J. Sanders, O. Anzala, V. Edward, L. G. Bekker, J. Tang, J. Gilmour, S. L. Kosakovsky-Pond, P. Phung, T. Wrin, S. Crotty, A. Godzik and P. Poignard (2016). "Broadly Neutralizing Antibody Responses in a Large Longitudinal Sub-Saharan HIV Primary Infection Cohort." PLoS Pathog 12(1): e1005369.

 

Lee, J. H., G. Ozorowski and A. B. Ward (2016). "Cryo-EM structure of a native, fully glycosylated, cleaved HIV-1 envelope trimer." Science 351(6277): 1043-1048.

 

MacLeod, Daniel T., Nancy M. Choi, B. Briney, F. Garces, Lorena S. Ver, E. Landais, B. Murrell, T. Wrin, W. Kilembe, C.-H. Liang, A. Ramos, Chaoran B. Bian, L. Wickramasinghe, L. Kong, K. Eren, C.-Y. Wu, C.-H. Wong, Matt A. Price, J. Gilmour, P. Fast, A. Kamali, Eduard J. Sanders, O. Anzala, S. Allen, E. Hunter, E. Karita, W. Kilembe, S. Lakhi, M. Inambao, V. Edward, L.-G. Bekker, S. L. Kosakovsky Pond, I. A. Wilson, D. R. Burton and P. Poignard "Early Antibody Lineage Diversification and Independent Limb Maturation Lead to Broad HIV-1 Neutralization Targeting the Env High-Mannose Patch." Immunity 44(5): 1215-1226.

 

Mahan, A. E., M. F. Jennewein, T. Suscovich, K. Dionne, J. Tedesco, A. W. Chung, H. Streeck, M. Pau, H. Schuitemaker, D. Francis, P. Fast, D. Laufer, B. D. Walker, L. Baden, D. H. Barouch and G. Alter (2016). "Antigen-Specific Antibody Glycosylation Is Regulated via Vaccination." PLoS Pathog 12(3): e1005456.

 

 

McCoy, L. E., M. J. van Gils, G. Ozorowski, T. Messmer, B. Briney, J. E. Voss, D. W. Kulp, M. S. Macauley, D. Sok, M. Pauthner, S. Menis, C. A. Cottrell, J. L. Torres, J. Hsueh, W. R. Schief, I. A. Wilson, A. B. Ward, R. W. Sanders and D. R. Burton (2016). "Holes in the Glycan Shield of the Native HIV Envelope Are a Target of Trimer-Elicited Neutralizing Antibodies." Cell Rep 16(9): 2327-2338.

               

Monaco, D. C., D. A. Dilernia, A. Fiore-Gartland, T. Yu, J. L. Prince, K. K. Dennis, K. Qin, M. Schaefer, D. T. Claiborne, W. Kilembe, J. Tang, M. A. Price, P. Farmer, J. Gilmour, A. Bansal, S. Allen, P. Goepfert and E. Hunter (2016). "Balance between transmitted HLA preadapted and nonassociated polymorphisms is a major determinant of HIV-1 disease progression." J Exp Med 

 

Molyneux, S., S. Sariola, D. Allman, M. Dijkstra, E. Gichuru, S. Graham, D. Kamuya, G. Gakii, B. Kayemba, B. Kombo, A. Maleche, J. Mbwambo, V. Marsh, M. Micheni, N. Mumba, M. Parker, J. Shio, C. Yah, E. van der Elst and E. Sanders (2016). "Public/community engagement in health research with men who have sex with men in sub-Saharan Africa: challenges and opportunities." Health Res Policy Syst 14(1): 40.

 

Moldt, B., K. Le, D. G. Carnathan, J. B. Whitney, N. Schultz, M. G. Lewis, E. Borducchi, K. Smith, J. J. Mackel, S. L. Sweat, A. P. Hodges, A. Godzik, P. W. Parren, G. Silvestri, D. H. Barouch and D. R. Burton (2016). "Neutralizing antibody affords comparable protection against vaginal and rectal SHIV challenge in macaques." AIDS.

 

Mutua, G., B. Farah, R. Langat, J. Indangasi, S. Ogola, B. Onsembe, J. T. Kopycinski, P. Hayes, N. J. Borthwick, A. Ashraf, L. Dally, B. Barin, A. Tillander, J. Gilmour, J. De Bont, A. Crook, D. Hannaman, J. H. Cox, O. Anzala, P. E. Fast, M. Reilly, K. Chinyenze, W. Jaoko, T. Hanke and T. Hiv-Core 004 Study Group (2016). "Broad HIV-1 inhibition in vitro by vaccine-elicited CD8(+) T cells in African adults." Mol Ther Methods Clin Dev 3: 16061.

 

Ngoi, C. N., M. A. Price, B. Fields, J. Bonventure, C. Ochieng, G. Mwashigadi, A. S. Hassan, A. N. Thiong'o, M. Micheni, P. Mugo, S. Graham and E. J. Sanders (2016). "Dengue and Chikungunya Virus Infections among Young Febrile Adults Evaluated for Acute HIV-1 Infection in Coastal Kenya." PLoS One 11(12): e0167508.

 

 

Nyombayire, J., O. Anzala, B. Gazzard, E. Karita, P. Bergin, P. Hayes, J. Kopycinski, G. Omosa-Manyonyi, A. Jackson, J. Bizimana, B. Farah, E. Sayeed, C. L. Parks, M. Inoue, T. Hironaka, H. Hara, T. Shu, T. Matano, L. Dally, B. Barin, H. Park, J. Gilmour, A. Lombardo, J.-L. Excler, P. Fast, D. S. Laufer and J. H. Cox (2016). "First-in-Human Evaluation of the Safety and Immunogenicity of a Replicating Intranasally Administered Sendai HIV-1 Gag Vaccine: Induction of Potent T-cell or Antibody Responses in Prime-Boost Regimens." Journal of Infectious Diseases:

 

 

 

               

Obuku, A. E., G. Asiki, A. Abaasa, I. Ssonko, A. Harari, G. J. van Dam, P. L. Corstjens, M. Joloba, S. Ding, J. Mpendo, L. Nielsen, A. Kamali, A. M. Elliott, G. Pantaleo, P. Kaleebu and P. Pala (2016). "Effect of Schistosoma mansoni infection on innate and HIV-1 specific T cell immune responses in HIV-1 infected Ugandan fisher folk." AIDS Res Hum Retroviruses.

 

 

Ondondo, B., H. Murakoshi, G. Clutton, S. Abdul-Jawad, E. G. Wee, H. Gatanaga, S. Oka, A. J. McMichael, M. Takiguchi, B. Korber and T. Hanke (2016). "Novel conserved-region T-cell mosaic vaccine with high global HIV-1 coverage is recognized by protective responses in untreated infection." Mol Ther.

 

 

Patil, S., R. Kumar, S. Deshpande, S. Samal, T. Shrivastava, S. Boliar, M. Bansal, N. K. Chaudhary, A. K. Srikrishnan, K. G. Murugavel, S. Solomon, M. Simek, W. C. Koff, R. Goyal, B. K. Chakrabarti and J. Bhattacharya (2016). "Conformational Epitope-Specific Broadly Neutralizing Plasma Antibodies Obtained from an HIV-1 Clade C Infected Elite Neutralizer Mediate Autologous Virus Escape through Mutations in V1 Loop." J Virol.

 

 

 

Prentice, H. A., H. Lu, M. A. Price, A. Kamali, E. Karita, S. Lakhi, E. J. Sanders, O. Anzala, S. Allen, P. A. Goepfert, E. Hunter, J. Gilmour and J. Tang (2016). "Dynamics and Correlates of CD8 T-Cell Counts in Africans with Primary Human Immunodeficiency Virus Type 1 Infection." J Virol 90(22): 10423-10430.

 

 

Safrit, J. T. and W. C. Koff (2016). "Novel approaches in preclinical HIV vaccine research."Curr Opin HIV AIDS. 

 

Stewart-Jones, Guillaume B. E., C. Soto, T. Lemmin, G.-Y. Chuang, A. Druz, R. Kong, Paul V. Thomas, K. Wagh, T. Zhou, A.-J. Behrens, T. Bylund, Chang W. Choi, Jack R. Davison, Ivelin S. Georgiev, M. G. Joyce, Young D. Kwon, M. Pancera, J. Taft, Y. Yang, B. Zhang, Sachin S. Shivatare, Vidya S. Shivatare, C.-Chun D. Lee, C.-Y. Wu, Carole A. Bewley, Dennis R. Burton, Wayne C. Koff, M. Connors, M. Crispin, U. Baxa, Bette T. Korber, C.-H. Wong, John R. Mascola and Peter D. Kwong "Trimeric HIV-1-Env Structures Define Glycan Shields from Clades A, B, and G." Cell.

           

Safrit, J. T., P. E. Fast, L. Gieber, H. Kuipers, H. J. Dean and W. C. Koff (2016). "Status of vaccine research and development of vaccines for HIV-1." Vaccine.

    

Safrit, J. T., G. D. Tomaras, T. Hanke, A. C. deCamp and Y. Voronin (2016). "The Landscape of Targeted Immune Responses in the HIV-1 Vaccine Field." AIDS Res Hum Retroviruses.

 

Smith, S. A., S. L. Burton, W. Kilembe, S. Lakhi, E. Karita, M. Price, S. Allen, E. Hunter and C. A. Derdeyn (2016). "Diversification in the HIV-1 Envelope Hyper-variable Domains V2, V4, and V5 and Higher Probability of Transmitted/Founder Envelope Glycosylation Favor the Development of Heterologous Neutralization Breadth." PLoS Pathog 12(11): e1005989.

 

 

Sok, D., M. Pauthner, B. Briney, J. H. Lee, K. L. Saye-Francisco, J. Hsueh, A. Ramos, K. M. Le, M. Jones, J. G. Jardine, R. Bastidas, A. Sarkar, C. H. Liang, S. S. Shivatare, C. Y. Wu, W. R. Schief, C. H. Wong, I. A. Wilson, A. B. Ward, J. Zhu, P. Poignard and D. R. Burton (2016). "A Prominent Site of Antibody Vulnerability on HIV Envelope Incorporates a Motif Associated with CCR5 Binding and Its Camouflaging Glycans." Immunity 45(1): 31-45.

 

 

Sok, D. and D. R. Burton (2016). "HIV Broadly Neutralizing Antibodies: Taking Good Care Of The 98." Immunity 45(5): 958-960.

 

 

Steichen, Jon M., Daniel W. Kulp, T. Tokatlian, A. Escolano, P. Dosenovic, Robyn L. Stanfield, Laura E. McCoy, G. Ozorowski, X. Hu, O. Kalyuzhniy, B. Briney, T. Schiffner, F. Garces, Natalia T. Freund, Alexander D. Gitlin, S. Menis, E. Georgeson, M. Kubitz, Y. Adachi, M. Jones, Andrew A. Mutafyan, Dong S. Yun, Christian T. Mayer, Andrew B. Ward, Dennis R. Burton, Ian A. Wilson, Darrell J. Irvine, Michel C. Nussenzweig and William R. Schief "HIV Vaccine Design to Target Germline Precursors of Glycan-Dependent Broadly Neutralizing Antibodies." Immunity.

 

Sok, D., B. Briney, J. G. Jardine, D. W. Kulp, S. Menis, M. Pauthner, A. Wood, E. C. Lee, K. M. Le, M. Jones, A. Ramos, O. Kalyuzhniy, Y. Adachi, M. Kubitz, S. MacPherson, A. Bradley, G. A. Friedrich, W. R. Schief and D. R. Burton (2016). "Priming HIV-1 broadly neutralizing antibody precursors in human Ig loci transgenic mice." Science.

               

 

Tian, M., C. Cheng, X. Chen, H. Duan, H. L. Cheng, M. Dao, Z. Sheng, M. Kimble, L. Wang, S. Lin, S. D. Schmidt, Z. Du, M. G. Joyce, Y. Chen, B. J. DeKosky, Y. Chen, E. Normandin, E. Cantor, R. E. Chen, N. A. Doria-Rose, Y. Zhang, W. Shi, W. P. Kong, M. Choe, A. R. Henry, F. Laboune, I. S. Georgiev, P. Y. Huang, S. Jain, A. T. McGuire, E. Georgeson, S. Menis, D. C. Douek, W. R. Schief, L. Stamatatos, P. D. Kwong, L. Shapiro, B. F. Haynes, J. R. Mascola and F. W. Alt (2016). "Induction of HIV Neutralizing Antibody Lineages in Mice with Diverse Precursor Repertoires." Cell 166(6): 1471-1484 e1418.

 

 

Wall, K. M., W. Rida, L. Haddad, A. Kamali, E. Karita, S. Lakhi, W. Kilembe, S. Allen, M. Inambao, A. H. Yang, M. H. Latka, O. Anzala, E. J. Sanders, L. G. Bekker, V. A. Edward and M. A. Price (2016). "Pregnancy and HIV disease progression in an early infection cohort from five African countries." Epidemiology.

 

 

           

Wang, Y., C. Sundling, R. Wilson, S. O'Dell, Y. Chen, K. Dai, G. E. Phad, J. Zhu, Y. Xiao, J. R. Mascola, G. B. Karlsson Hedestam, R. T. Wyatt and Y. Li (2016). "High-Resolution Longitudinal Study of HIV-1 Env Vaccine-Elicited B Cell Responses to the Virus Primary Receptor Binding Site Reveals Affinity Maturation and Clonal Persistence." J Immunol.

 

 

Zeng, M., A. J. Smith, L. Shang, S. W. Wietgrefe, J. E. Voss, J. V. Carlis, Q. Li, M. Piatak, Jr., J. D. Lifson, R. P. Johnson and A. T. Haase (2016). "Mucosal Humoral Immune Response to SIVmac239nef Vaccination and Vaginal Challenge." J Immunol.